David P. van der Ham

Induction of Labor versus Expectant Management in Women with Preterm Prelabor Rupture of Membranes between 34 and 37 Weeks: A Randomized Controlled Trial

David P. van der Ham, Sylvia Vijgen, Jan G. Nijhuis et al. · PLoS Medicine · 2012 · 203 citations · Full text

Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial

David P. van der Ham, Jantien L. van der Heyden, Brent C. Opmeer et al. · American Journal of Obstetrics and Gynecology · 2012 · 194 citations · Full text

Ppromexil-2 Trial, Preterm Premature Rupture Of Membranes, Surgery +1

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Ingrid M. Bistervels, Andréa Buchmuller, Hanke M.G. Wiegers et al. · The Lancet · 2022 · 93 citations · Full text

Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry

Josje Langenveld, Anita C.J. Ravelli, Anton H. van Kaam et al. · American Journal of Obstetrics and Gynecology · 2011 · 75 citations · Full text

Hypertension, Gestational Hypertension, National Registry +12

Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial

Anadeijda J. E. M. C. Landman, Marjon A. de Boer, Laura Visser et al. · PLoS Medicine · 2022 · 65 citations · Full text